Nerve block may offer better relief for frozen shoulder than standard joint injection

NCT ID NCT05909462

Completed Symptom relief Sponsor: Hitit University Source: ClinicalTrials.gov ↗

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study compares two ultrasound-guided injection treatments for adhesive capsulitis, also known as frozen shoulder. One group receives a steroid and numbing medicine injected directly into the shoulder joint, while the other group gets the same medicine injected near the suprascapular nerve. Researchers measure pain, shoulder function, and range of motion before treatment, at ten days, and at three months. The goal is to see which method provides better and longer-lasting relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: triamcinolone acetonide and lidocaine
What this could lead to: If one method proves clearly better, it could become the preferred injection technique for frozen shoulder, offering faster pain relief and improved movement.
What could go wrong: This is a small, single-center trial with 60 participants, so results may not apply to everyone. Both injections carry risks like infection or nerve damage, and long-term benefits are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHESIVE CAPSULITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bursitis frozen shoulder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHESIVE CAPSULITIS

Contacts and locations

Locations

Hitit University

Çorum, 19030, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.